Kenneth Hu, MD, Radiation Oncology, New York, NY, NYU Langone Hospitals

KennethSHuMDFASTRO

Radiation Oncology New York, NY

Associate Professor, Radiation Oncology, New York College of Medicine

Overview of Dr. Hu

Dr. Kenneth Hu is a radiation oncologist in New York, NY and is affiliated with NYU Langone Hospitals. He received his medical degree from Harvard Medical School and has been in practice 23 years. Dr. Hu accepts several types of health insurance, listed below. He is one of 33 doctors at NYU Langone Hospitals who specialize in Radiation Oncology.

Education & Training

  • Memorial Sloan-Kettering Cancer CenterResidency, Radiation Oncology, 1995 - 1998
  • Harvard Medical SchoolClass of 1994
  • University of California Los AngelesB.S., Summa Cum Laude, 1983 - 1988

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2013 - 2019
  • NY State Medical License
    NY State Medical License 1996 - 2023
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Fellowship Exchange Award ASTRO/ESTRO, 2000
  • Berlex Oncology Foundation Award 1995
  • Medical Student Research Fellowship Howard Hughes Medical Institute, 1991
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Postoperative radiation therapy for parotid pleomorphic adenoma with close or positive margins: treatment outcomes and toxicities  
    Patel S, Mourad WF, Wang C, Dhanireddy B, Concert C, Ryniak M, Khorsandi AS, Shourbaji RA, Li Z, Culliney B, Patel R, Bakst RL, Tran T, Shasha D, Schantz S, Persky MS,..., Anticancer Res, 1/1/2014
  • Initial experience with oropharynx-targeted radiation therapy for metastatic squamous cell carcinoma of unknown primary of the head and neck  
    Mourad WF, Hu KS, Shasha D, Concert C, Ishihara D, Lin W, Shourbaji RA, Ryniak M, Gamez ME, Lukens JN, Li Z, Culliney BE, Khorsandi AS, Tran T, Jacobson A, Manolidis S..., Anticancer Res, 1/1/2014
  • Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subject...  
    Limaye SA, Haddad RI, Cilli F, Sonis ST, Colevas AD, Brennan MT, Hu KS, Murphy BA, Cancer, 1/15/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Role of Radiation Therapy in the Management of Nasopharynx Cancer 
    New York, NY - 1/1/2014
  • Current Management and Future Directions of Oropharynx Cancer 
    Tampa, FL - 1/1/2014
  • Current Management of Oropharynx Cancer 
    1/1/2014
  • Join now to see all

Press Mentions

  • New Division of Oncological Rehabilitation Improves Quality of Life in People with Cancer
    New Division of Oncological Rehabilitation Improves Quality of Life in People with CancerDecember 6th, 2018
  • Twenty-Three ASTRO Members Awarded Fellows Designation
    Twenty-Three ASTRO Members Awarded Fellows DesignationAugust 2nd, 2017
  • Vision-Sparing Approach for a Rare Sinonasal Malignancy Enables Resection & Recovery
    Vision-Sparing Approach for a Rare Sinonasal Malignancy Enables Resection & RecoveryMarch 8th, 2019

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    Healthfirst New York
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment